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by the number of transplants that are part of the CIBMTR
Outcomes Research Database underlines the need for
structures that document this ’data about data’ (Metadata).
The difﬁculty is showing how the complete set of data
around a transplant event is connected in a way that
transcends the collection method, i.e. form. Our aim was to
demonstrate that a domain-driven architecture aligns with
the forms-based model, and eases the introduction of
collecting more data about HCT transplant events. The
Biomedical Research Integrated Domain Group (BRIDG)
model is publically available. The goal of BRIDG group is to
have a common view of the data exchanged for semantic
interoperability. The BRIDG model is intended to balance
the concerns of the larger health care community, while
being speciﬁc enough to apply to a particular subject area
such as HCT. We extracted all Common Data Elements
(CDEs) for all CIBMTR-mandated forms and associated each
element to one of three contexts, Recipient, Donor and
stem-cell product; most elements were in the Recipient
context. Because no element could be described in isola-
tion, instance diagrams were created to describe how one
simple concept needed multiple BRIDG entities to be fully
described. Some CDEs were described as relationships
between entities rather than an attribute of an entity. We
extended the generic BRIDG model to contain all identiﬁed
elements. To this end, we requested the expansion of the
BRIDG model to include a ’PerformedSubstanceExtraction’
entity at the same level of inheritance as ’Perform-
edSubstanceAdministration’. While the collection of a
stem-cell product could have been described in the context
of a ’Product’ and a ’SpecimenCollection’, the richness of
the relationship between a Donor and a Recipient would
not have been as obvious. This as well as other enhance-
ments to the BRIDG model were included in BRIDG version
3.2. With this effort, we have documented each data point
(CDE) collected on all the CIBMTR-mandated forms and the
relationships between them. We intend to use the UML
BRIDG model with the added HCT content as the speciﬁ-
cation for a physical database model. This physical model
will help remove barriers that transplant centers experi-
ence in electronic transfer of HCT data to the Stem Cell
Transplant Outcomes Database by providing a foundation
upon which to develop their own in-house data systems,
and eventual development of Electronic Medical Record
(EMR) integration engines to submit data to the Outcomes
Database.315
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Background: Interpersonal communication is an intangible
- and often overlooked - barrier to data management and
error reduction. Reporting to the Center for International
Blood and Marrow Transplant Research (CIBMTR) and in-
ternal databases requires comprehensive data manage-
ment techniques e including communication processes.
Facilitation of interpersonal communication among clinical
teams has become increasingly important in healthcare
due to potentially adverse outcomes of a communicationfailure (see Leonard, Graham, & Bonacum, 2004; Marshal,
Harrison, & Flanagan, 2009; Propp et. al, 2010) Sutcliffe,
Lewton, & Rosenthal, 2004). A poor BMT Physician-
research coordinator relationship may result in closed
communication, a lack of transparency throughout the
clinical team, and insufﬁcient data collection and reporting
to CIBMTR. Thus, we recommend actions targeted at
removing barriers to reciprocal physician-coordinator
communication.
Methods targeting improved communication: (a.) Physi-
cian Sign-off: physician-reviewed data veriﬁcation encour-
ages open discussion and review of essential CIBMTR data
prior to transplant; (b.) Rounding: opportunities to attend in-
patient rounds with the entire clinical team increases coor-
dinator knowledge base and permits a transparent view of
the continuum of care. (c.) Research Nurse Relationships:
highly-accessible and responsive nurses serve as key liaisons
between coordinators and the clinical team; (d.) Disease
In-service & Education: small group continuing education
sessions allow teaching moments between physicians and
coordinators; (e.) Direct and Real-Time communication:
reducing hierarchical barriers allows any team member to
directly contact/speak to a physician or use electronic
communication to share patient status updates (e.g., re-
lapses, deaths); (f.) Team Engagement Events: social events
encourage networking and relationship development (e.g.,
NMDP Be the Match - Toss the boss, Leukemia & Lymphoma
Society, and after work events).
Future: Interpersonal communication is essential to our
good clinical practices and embedded in our standard
operating procedures. Removing communication barriers
and improving relationships has been a critical success
factor for our team. Our objective is to continue identifying
communication failures while maintaining reciprocal re-
lationships e particularly during times of turnover and
transition.316
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Background: AE capture and reporting is one of the most
time-consuming activities related to the conduct of he-
matopoietic stem cell transplant (HSCT) clinical trials, with
some trials requiring hundreds of AEs to be captured and
summarized for reporting. To improve the AE reporting
process, our HSCT Program collaborated with the Univer-
sity of Virginia Biomedical Informatics Division of the
Public Health Sciences Department to develop a novel
electronic data capture tool. The purpose of this study was
to evaluate the tool’s efﬁciency and identify areas for
improvement.
Methods: The electronic tool was designed to be quick,
simple to use, and easy to deploy. Microsoft Excel array for-
mulas were used, allowing a calculation to be carried out
Figure 1. Automatic summary of date range and highest grade produced for 25 captured events.
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requiring the user to initiate the calculation. As each AE is
captured, summary data are updated dynamically with start
date, end date, and highest grade (Figure 1). AEs from 5mock
subjects, with 100 data points each, were captured and
recorded by 2 separate users by the traditional paper method
and the electronic method. The paper method captured AEs
upon grade change only, and the electronic tool captured all
AEs with and without grade changes. The start date, end
date, and highest grade of AEs were reported in a mock
database. The time interval for data capture and reporting for
each subject was recorded by the user and compared be-
tween the 2 modalities. The capture and reporting of events
was measured per second.
Results: The electronic tool captured 446 AEs, and the pa-
per method captured 175 grade change AEs. The time in-
terval of AE capture using the electronic tool was shorter in
1 user, even with the capture of an additional 271 events.
The time interval of AE reporting was shorter for both users
with the electronic tool. The average time of data capture
using the electronic tool was 9.56 sec/event, and 24.46 sec/
event using the paper format, making the electronic tool
2.5-fold faster for AE capture. The average time of data
reporting using the electronic tool was 2.10 sec/event, and
10.20 sec/event using the paper format, making the elec-
tronic tool 4.8-fold faster for data reporting. Overall, the
electronic tool was on average 23 seconds faster per event,
and 2.9-fold faster per event for AE capture and reporting
combined.Figure 1. SP automated expansConclusions: The electronic tool is more time efﬁcient
per event for both AE capture and reporting. Use of the
electronic tool can be improved by modifying parameters
for AE capture to shorten data capture time. The electronic
tool can be applied in the clinic setting with an electronic
tablet for real-time AE collection. Use of the electronic
tool in an investigator-initiated trial was successful. We
intend to evaluate accuracy of the electronic versus
paper method and to apply the tool in a Sponsored clinical
trial.317
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Background: The University of Virginia (UVA) Stem Cell
Transplant (SCT) Program has performed 28 allogeneic and
39 autologous transplants since opening in January 2012. Fullion into customary text
